UNSPSC 51172832: Hydrogen peroxide/povidone iodine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR500. This VA Drug Class (OR500) classifies this compound as belonging to the group MOUTHWASHES.

UNSPSC 51172832 Hydrogen peroxide/povidone iodine is a Commodity code that captures antiseptic and disinfectant pharmaceutical products state and local governments procure for healthcare delivery, medical facilities, and institutional use. State and local buying under this code flows through cooperative purchasing vehicles and multi-source pharmaceutical agreements that consolidate demand across multiple jurisdictions and facility types. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary issuing body active in this space, leveraging cooperative structures to aggregate purchasing power across participating state agencies, local government facilities, and healthcare institutions in multiple states including Oregon. Work solicited under the code involves manufacturers and wholesaler-authorized vendors supplying pharmaceuticals and over-the-counter products with full compliance to current Good Manufacturing Practices (cGMP), Drug Supply Chain Security Act (DSCSA) certification, and FDA requirements, with detailed National Drug Code (NDC), SKU, UPC, and packaging configuration data submission.

MMCAP's January 2026 Request for Proposal for Generic Multi Source Pharmaceuticals and OTC Products (Solicitation S1070000015802, due March 26, 2026) represents the most recent relevant opportunity under this code. The procurement establishes multiple contracts for products distributed across participating state and local government facilities, with awards effective July 1, 2026, and a two-year initial term. Vendors must maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), maintain comprehensive insurance including $5 million commercial general liability and $2 million network security and privacy liability, and accept pricing weighted heavily on competitiveness (75 percent evaluation weight) alongside compliance, EDI capability, and administrative fee agreement. No specific set-asides or disadvantaged-enterprise restrictions are identified in available documentation. The cooperative purchasing vehicle and multi-state scope indicate geographic activity centered in the upper Midwest and Pacific Northwest, though MMCAP's administrative structure and member participation extend the potential market across additional jurisdictions.